Teleflex (TFX)
(Delayed Data from NYSE)
$206.71 USD
0.00 (0.00%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $206.79 +0.08 (0.04%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Teleflex Incorporated [TFX]
Reports for Purchase
Showing records 421 - 440 ( 460 total )
Company: Teleflex Incorporated
Industry: Medical - Instruments
Industry: Takeaways from SAGES Meetings; Incrementally Positive on TFX - HRC
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Organic Growth and Margin Trajectory Strengthening into 2016; Raise PT to $159
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Industry: 4Q Earnings Preview; Results Likely in Line; Cautious Around 2016 Guidance
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
2016 KBCM Healthcare Outlook
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Initial Results from the Cleveland Clinic on Percuvance Now Available
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Impact of Potential Government Spending Agreement on Medical Products/Life Science Tools Coverage
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
A Minimally Invasive Path to Organic Growth; Raising Awareness Ahead of 1Q16 Commercial Launch
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Mixed Results; Lower Sales - Gross Margin Offset by a Better Tax Rate
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Managing Through a Challenging NT Environment; Maintain Our Bullish LT Outlook
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Street Estimates Did Not Necessarily Reflect Investor Expectations
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Gross Margin Trending in the Right Direction; Single Datapoints Dont Change That
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Management Meetings Reinforce Our Positive LT Earnings Outlook; Raising PT
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Base Case Double-Digit Earnings Growth with Upside from Capital Allocation - Percuvance; Raising PT
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
First Look: YOY Gross Margin Improvement Encouraging
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Setting Themselves Up for its Analyst Day
Provider: KEYBANC CAPITAL MARKETS
Company: Teleflex Incorporated
Industry: Medical - Instruments
Underlying Business Outperforming Expectations; Raising PT
Provider: KEYBANC CAPITAL MARKETS